thiophenes has been researched along with Genetic Predisposition in 15 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (26.67) | 29.6817 |
| 2010's | 10 (66.67) | 24.3611 |
| 2020's | 1 (6.67) | 2.80 |
| Authors | Studies |
|---|---|
| Al-Obaidy, KI; Cheng, L | 1 |
| Beauchamp, J; Billon, C; Boulinguiez, A; Burris, TP; Delhaye, S; Dombrowicz, D; Duez, HM; Duhem, C; Eeckhoute, J; Ferri, L; Haas, JT; Lancel, S; Mayeuf-Louchart, A; Pourcet, B; Sebti, Y; Sitaula, S; Staels, B; Thorel, Q; Vanhoutte, J; Zecchin, M | 1 |
| Beatty, NC; Curry, TB; Eisenach, JH; Langman, LJ; Nicholson, WT | 1 |
| Davis, RM; Grubbs, J; Huynh, K; Liu, KC | 1 |
| Behnen, M; Bieber, K; de Castro Marques, A; Gupta, Y; Ibrahim, SM; Kalies, K; Kasprick, A; Laskay, T; Ludwig, RJ; Mariani, J; Möller, S; Müller, S; Recke, A; Sadeghi, H; Samavedam, UK; Schmidt, E; Zillikens, D | 1 |
| Ang, SB; Chan, MM; Lee, HY; Lim, YL; Pang, SM; Ren, EC; Shen, MX; Tay, YK; Xiao, ZW | 1 |
| Ma, A; Wang, J; Zhao, M; Zhu, H | 1 |
| Hayden, EC | 1 |
| Armamento-Villareal, R; Cole, E; Early, DS; Gao, F; Gorbe, E; Ha, CY; Nagler, A; Napoli, N | 1 |
| Ringe, JD | 1 |
| Berger, JS; Hochman, JS; Ladapo, JA; Lala, A; Scott Braithwaite, R; Sharma, G | 1 |
| Mazur-Bialy, AI; Undas, A; Wypasek, E; Zdebska, K | 1 |
| Bouchard, G; Carey, MC; Clarke, GA; Paigen, B | 1 |
| Akaza, H; Hattori, K; Iida, K; Itoh, K; Kawai, K; Kumagai, Y; Oyasu, R; Shimazui, T; Yamamoto, M | 1 |
| Brenner, DE; Krishnan, K; Ruffin, MT | 1 |
4 review(s) available for thiophenes and Genetic Predisposition
| Article | Year |
|---|---|
Fibroblast growth factor receptor (
Topics: Antineoplastic Agents; Biomarkers, Tumor; Carcinoma; Exons; Gene Amplification; Gene Fusion; Genetic Predisposition to Disease; Humans; Molecular Targeted Therapy; Mutation, Missense; Phenotype; Phenylurea Compounds; Piperazines; Protein Kinase Inhibitors; Pyrazoles; Pyrimidines; Pyrroles; Quinoxalines; Receptor, Fibroblast Growth Factor, Type 3; Thiophenes; Urinary Bladder Neoplasms; Urothelium | 2021 |
Autoimmunity in the pathogenesis and treatment of keratoconjunctivitis sicca.
Topics: Animals; Antigen-Presenting Cells; Apoptosis; Autoantibodies; Autoimmunity; Cyclosporine; Genetic Predisposition to Disease; Humans; Immunity, Cellular; Immunity, Humoral; Keratoconjunctivitis Sicca; Molecular Mimicry; Quinuclidines; Sjogren's Syndrome; T-Lymphocytes, Helper-Inducer; T-Lymphocytes, Regulatory; Thiophenes | 2014 |
Strontium ranelate: an effective solution for diverse fracture risks.
Topics: Body Mass Index; Bone Density Conservation Agents; Female; Genetic Predisposition to Disease; Glucocorticoids; Humans; Male; Organometallic Compounds; Osteoporosis; Osteoporotic Fractures; Risk Factors; Smoking; Thiophenes | 2010 |
Chemoprevention for colorectal cancer.
Topics: Adenoma; Animals; Anti-Inflammatory Agents, Non-Steroidal; Anticarcinogenic Agents; Antioxidants; Apoptosis; Arachidonic Acids; Bile Acids and Salts; Biomarkers; Calcium; Cell Cycle; Cell Transformation, Neoplastic; Clinical Trials as Topic; Colonic Polyps; Colorectal Neoplasms; DNA Methylation; DNA Repair; Eflornithine; Enzyme Inhibitors; Estrogens; Free Radical Scavengers; Genetic Predisposition to Disease; Humans; Mice; Ornithine Decarboxylase Inhibitors; Patient Compliance; Patient Selection; Polyamines; Precancerous Conditions; Pyrazines; Rats; Retinoids; Thiones; Thiophenes; Tumor Cells, Cultured; Vitamins | 2000 |
11 other study(ies) available for thiophenes and Genetic Predisposition
| Article | Year |
|---|---|
Nuclear Receptor Subfamily 1 Group D Member 1 Regulates Circadian Activity of NLRP3 Inflammasome to Reduce the Severity of Fulminant Hepatitis in Mice.
Topics: Animals; Caspase 1; Cells, Cultured; Chemical and Drug Induced Liver Injury; Circadian Rhythm; Cytokines; Disease Models, Animal; Galactosamine; Genetic Predisposition to Disease; Inflammasomes; Lipopolysaccharides; Liver; Liver Failure, Acute; Macrophage Activation; Macrophages, Peritoneal; Mice, Knockout; NLR Family, Pyrin Domain-Containing 3 Protein; Nuclear Receptor Subfamily 1, Group D, Member 1; Peritonitis; Phenotype; Pyrrolidines; RNA Interference; Severity of Illness Index; Signal Transduction; Thiophenes; Time Factors; Transfection | 2018 |
Pharmacogenetic workup of perioperative serotonin syndrome.
Topics: Anesthesia, General; Cytochrome P-450 CYP2D6; Drug Interactions; Duloxetine Hydrochloride; Genetic Predisposition to Disease; Humans; Male; Middle Aged; Postoperative Complications; Selective Serotonin Reuptake Inhibitors; Serotonin Syndrome; Thiophenes | 2013 |
The retinoid-related orphan receptor alpha is essential for the end-stage effector phase of experimental epidermolysis bullosa acquisita.
Topics: Animals; Autoantibodies; Collagen Type VII; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Partial Agonism; Epidermolysis Bullosa Acquisita; Genetic Predisposition to Disease; Genomics; Haplotypes; Heterozygote; Homozygote; Immunoglobulin G; Mice, Knockout; Neutrophil Activation; Neutrophils; Nuclear Receptor Subfamily 1, Group F, Member 1; Phenotype; Reactive Oxygen Species; Signal Transduction; Skin; Species Specificity; Sulfonamides; Thiophenes; Time Factors | 2015 |
Increased risk of strontium ranelate-related SJS/TEN is associated with HLA.
Topics: Aged; Aged, 80 and over; Anticonvulsants; Asian People; Case-Control Studies; China; Female; Genetic Predisposition to Disease; HLA-A Antigens; HLA-B Antigens; Humans; Leukocytes, Mononuclear; Male; Osteoporosis; Retrospective Studies; Stevens-Johnson Syndrome; Thiophenes | 2016 |
AMPK activation reduces the number of atheromata macrophages in ApoE deficient mice.
Topics: Aminoimidazole Carboxamide; AMP-Activated Protein Kinases; Animals; Antigens, Ly; Aorta; Aortic Diseases; Apolipoproteins E; Atherosclerosis; Biphenyl Compounds; Cell Line; Cell Migration Inhibition; Chemotaxis; Disease Models, Animal; Enzyme Activation; Enzyme Activators; Genetic Predisposition to Disease; Humans; Macrophages; Metformin; Mice, Knockout; Phenotype; Pyrones; Receptors, CCR2; Ribonucleotides; Signal Transduction; Thiophenes | 2017 |
Cardiovascular disease gets personal.
Topics: Anticoagulants; Cardiovascular Diseases; Clinical Trials as Topic; Clopidogrel; Female; Genetic Predisposition to Disease; Genetic Testing; Genetic Variation; Genome-Wide Association Study; Genomics; Humans; Pharmacogenetics; Piperazines; Platelet Aggregation Inhibitors; Prasugrel Hydrochloride; Thiophenes; Ticlopidine; Warfarin | 2009 |
The association between a functional CYP1A1 polymorphism and colorectal neoplasia risk in post menopausal women.
Topics: Aged; Colorectal Neoplasms; Cytochrome P-450 CYP1A1; Estrogens; Female; Furans; Genetic Predisposition to Disease; Genotype; Humans; Middle Aged; Polymorphism, Restriction Fragment Length; Postmenopause; Risk Factors; Thiophenes | 2010 |
Genetic testing in patients with acute coronary syndrome undergoing percutaneous coronary intervention: a cost-effectiveness analysis.
Topics: Acute Coronary Syndrome; Aryl Hydrocarbon Hydroxylases; Cerebrovascular Disorders; Clopidogrel; Computer Simulation; Cost-Benefit Analysis; Cytochrome P-450 CYP2C19; Decision Support Techniques; Disease-Free Survival; Drug Costs; Gene Frequency; Genetic Predisposition to Disease; Genetic Testing; Health Care Costs; Hemorrhage; Humans; Insurance, Health, Reimbursement; Kaplan-Meier Estimate; Markov Chains; Medicare; Models, Economic; Myocardial Infarction; Percutaneous Coronary Intervention; Pharmacogenetics; Phenotype; Piperazines; Platelet Aggregation Inhibitors; Prasugrel Hydrochloride; Predictive Value of Tests; Quality-Adjusted Life Years; Risk Assessment; Risk Factors; Thiophenes; Thrombosis; Ticlopidine; Time Factors; Treatment Outcome; United States | 2013 |
Repeated bleeding complications during therapy with vitamin K antagonists in a patient with the VKORC1*2A and the CYP2C9*3/*3 alleles: genetic testing to support switching to new oral anticoagulants.
Topics: Administration, Oral; Adult; Anticoagulants; Aryl Hydrocarbon Hydroxylases; Cytochrome P-450 CYP2C9; Exons; Female; Genetic Predisposition to Disease; Genetic Testing; Genotype; Haplotypes; Hemorrhage; Humans; Hypertension; Mixed Function Oxygenases; Morpholines; Mutation; Poland; Rivaroxaban; Thiophenes; Vitamin K; Vitamin K Epoxide Reductases; Warfarin | 2013 |
Cholesterol synthesis inhibition distal to squalene upregulates biliary phospholipid secretion and counteracts cholelithiasis in the genetically prone C57L/J mouse.
Topics: Animals; Anticholesteremic Agents; Benzophenones; Bile; Bile Canaliculi; Cholelithiasis; Cholesterol; Enzyme Inhibitors; Genetic Predisposition to Disease; Intramolecular Transferases; Lipid Metabolism; Liver; Male; Mice; Mice, Inbred AKR; Mice, Inbred C57BL; Oxygenases; Phospholipids; Squalene Monooxygenase; Thiophenes | 2004 |
Nrf2 is essential for the chemopreventive efficacy of oltipraz against urinary bladder carcinogenesis.
Topics: Animals; Anticarcinogenic Agents; Butylhydroxybutylnitrosamine; Carcinogens; DNA-Binding Proteins; Enzyme Induction; Female; Gene Expression; Genetic Predisposition to Disease; Glucuronides; Glucuronosyltransferase; Inactivation, Metabolic; Male; Mice; Mice, Inbred C57BL; Mice, Inbred ICR; Mice, Knockout; Microsomes, Liver; NF-E2-Related Factor 2; Pyrazines; Thiones; Thiophenes; Trans-Activators; Urinary Bladder; Urinary Bladder Neoplasms | 2004 |